Stem Cell Transplantation in Cancer Treatment: Current Status and Future Direction
A special issue of Hematology Reports (ISSN 2038-8330).
Deadline for manuscript submissions: closed (2 February 2024) | Viewed by 559
Special Issue Editors
Interests: acute lymphoblastic leukemia; acute myeloid leukemia; myelodysplastic syndromes; multiple myeloma and MGUS; non-Hodgkin and Hodgkin lymphoma
Special Issues, Collections and Topics in MDPI journals
Interests: leukemias; lymphomas; acute leukemia; chronic myeloid leukemia
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Stem cell transplantation (SCT) has emerged as a well-established treatment for various malignant and non-malignant diseases of hematopoietic origin.
In recent years, improvements in transplantation techniques have led to a significant reduction in treatment-related complications. Importantly, mortality rates have declined in recent decades, despite increasing numbers of older patients and those with more comorbidities undergoing allogeneic HSCT.
This Special Issue focuses on the role of SCT in challenging cancer treatment options, covering both basic research and more clinical aspects that may advance our understanding of this intriguing process.
Dr. Claudio Cerchione
Dr. Giovanni Martinelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Hematology Reports is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
